Stock market strategy: Volatility to continue amid muted Q2 results, says Seshadri Sen; suggests buying on weakness

  • Stock market strategy: Consumer Discretionary and Industrials sectors are expected to report relatively strong Q1 numbers, but that is largely in the price, and forward guidance and commentary will carry greater weight than the Q2FY25 earnings reports.

Ankit Gohel
Published10 Oct 2024, 12:24 PM IST
Trade Now
Stock market strategy: The consensus forecasts for FY25 Nifty EPS (Earnings Per Share) growth are resilient at 15.9%.
Stock market strategy: The consensus forecasts for FY25 Nifty EPS (Earnings Per Share) growth are resilient at 15.9%.(Image: Pixabay)

The corporate earnings for the second quarter of FY25 are expected to be muted with high sector divergence, and the stock market volatility will continue in the near future, analysts said. While Materials, Energy, and Financials are likely to drag the aggregate net profit growth of Nifty to 5%, other sectors are expected to post a healthy high-teen growth.

The consensus forecasts for FY25 Nifty EPS (Earnings Per Share) growth are resilient at 15.9%, said Seshadri Sen, Head Of Research And Strategist at Emkay Global Financial Services Ltd. He expects the volatility in the markets to continue for a few more quarters and advises long-term investors to buy into this weakness with a horizon of more than two years.

Q2 Results

The topline growth for companies under Emkay Global universe is estimated to remain muted at 3% YoY, with near-zero net profit growth.

“This has been dragged by cement (due to an unusually pronounced seasonality) and Energy companies (due to a high base, which normalizes in 2HFY25). The rest of our universe reports a healthier 7.7% YoY topline growth and 12.7% YoY PAT growth,” Sen said.

Also Read | Q2 FY25 to see slowest earnings growth for Nifty companies in 17 quarters: MOFSL

The trends are similar for consensus Nifty estimates, with 3% topline contraction and 9% net profit growth. Despite the weak topline, margins are forecast to improve by 140 bps to 20.2% for Nifty 50 companies, ex-BFSI.

The consensus Nifty FY25 EPS has been steady at 1,134, a growth of 15.9% YoY, despite the weak headline H1. Around 67.5% of the top-350 companies by Emkay coverage were in the stable zone of EPS forecasts (-5% to +10% change) in 2QFY25 versus 65.4% in Q1FY25.

Sen believes the two downside risks to earnings are crude prices staying at or above $80 per barrel and a 50 bps RBI repo rate cut in Q3FY25, putting bank earnings at risk.

Sectoral Winners and Losers

Consumer Discretionary and Industrials sectors are expected to report relatively strong Q1 numbers, but that is largely in the price, and forward guidance and commentary will carry greater weight than the Q2FY25 earnings reports, according to Emkay Global.

Materials (led by cement), Energy, and Financials are expected to be the negative outliers.

Also Read | TCS Q2 Results Preview: Net profit seen up 4%, revenue may grow over 2% QoQ

Hindustan Unilever, oil marketing companies, and select midcap IT names like Eclerx Services could see a positive reaction after the results, while Tata Consultancy Services (TCS), Aditya Birla Fashion and Retail, and Zee Entertainment Enterprises (ZEEL) are vulnerable to post-result corrections, Sen said.

Market Outlook

The Indian stock market is expected to remain rangebound with heightened volatility. According to the Emkay Global, the upside is capped by valuations as its September 2025 target for the Nifty 50, at a generous 22x PER 1-Year Forward, is 26,000 and offers less than 5% upside from here.

“The downside is also protected, we believe, by sustained earnings growth and unprecedented macro-financial stability. The recent market sell-off is unlikely to translate into a major correction for broader indices. The big negatives - an oil shock from the Middle-East conflict and diversion of FPI flows to China - are transient, in our view,” Sen said.

Also Read | India outperforms EM peers in crude oil correction: Experts bet on THESE sectors

RBI Policy Impact

On October 9, the Reserve Bank of India’ (RBI) Monetary Policy Committee (MPC) decided to keep the benchmark repo rate unchanged at 6.5%, but changed the policy stance to ‘Neutral’ from ‘Withdrawal of Accommodation’.

According to Sen, RBI’s decision to hold rates will have little impact, while the turn in liquidity stance is a positive, he sees the easing cycle commencing in the December MPC meeting.

Also Read | RBI Monetary Policy Meeting Highlights: RBI sets tone for potential rate cuts

“The interregnum (easier liquidity and rates on hold) is a sweet spot for banks, as it notionally helps liabilities without triggering loan yield cuts. Stocks could react positively if the market sees rate cuts getting delayed, with HDFC Bank benefiting the most. We would see that as purely a short term trade though, and use it to lighten positions in the BFSI sector,” Sen said.

For the broader markets, he believes the rate easing cycle is in the price and unlikely to trigger a major move.

Read TCS Q2 Results Live Updates here

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:10 Oct 2024, 12:24 PM IST
Business NewsMarketsStock MarketsStock market strategy: Volatility to continue amid muted Q2 results, says Seshadri Sen; suggests buying on weakness

Most Active Stocks

Tata Steel share price

155.25
03:58 PM | 16 OCT 2024
-0.4 (-0.26%)

Tata Power share price

460.35
03:58 PM | 16 OCT 2024
-3.15 (-0.68%)

Bharat Petroleum Corporation share price

350.85
03:57 PM | 16 OCT 2024
1.65 (0.47%)

Bharat Electronics share price

285.65
03:49 PM | 16 OCT 2024
-3.15 (-1.09%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Coforge share price

7,120.75
10:51 AM | 7 OCT 2024
-2.4 (-0.03%)

Vijaya Diagnostic Centre share price

984.80
10:51 AM | 7 OCT 2024
-4.15 (-0.42%)

Dr. Lal Pathlabs share price

3,408.00
10:50 AM | 7 OCT 2024
-86.25 (-2.47%)
More from 52 Week High

Bombay Burmah Trading Corporation share price

2,519.95
10:51 AM | 7 OCT 2024
-245.3 (-8.87%)

Jubilant Ingrevia share price

728.55
10:51 AM | 7 OCT 2024
-65.7 (-8.27%)

Triveni Engineering & Indus share price

426.65
10:51 AM | 7 OCT 2024
-35.75 (-7.73%)

Vodafone Idea share price

9.08
10:51 AM | 7 OCT 2024
-0.72 (-7.35%)
More from Top Losers

Astrazeneca Pharma India share price

7,832.35
10:51 AM | 7 OCT 2024
399.85 (5.38%)

Finolex Industries share price

280.85
10:51 AM | 7 OCT 2024
9.2 (3.39%)

Macrotech Developers share price

1,206.20
10:51 AM | 7 OCT 2024
34.35 (2.93%)

JK Lakshmi Cement share price

797.60
10:51 AM | 7 OCT 2024
17.2 (2.2%)
More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      77,405.000.00
      Chennai
      77,411.000.00
      Delhi
      77,563.000.00
      Kolkata
      77,415.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00

      Popular in Markets

        HomeMarketsPremiumInstant LoanMint Shorts